glp 1 perimenopause Ashley Koff on GLP-1s and Weight in Perimenopause: When They Help, When They Harm, and the Red Flags You're Missing Using GLP-1 in Perimenopause? This

In a 16-week study, individuals with obesity and T2D who adhered to a KD regimen experienced an average weight loss of 6.6% and a 16% reduction in HbA1c levels [83].When utilized for the management of T2D, the KD has been associated with weight loss among study participants with minimal side effects [74, 75]

GLP-1 analogues have also been reported to prevent and reverse monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways [40], and to improve hypoxia-induced pulmonary hypertension in mice partly via normalization of reduced ET(B) receptor expression [41]

This study had been registered in Chinese Clinical Trial Registry (No

More about this product

Redox Biol 51:102273 Deng J, Pan W, Ji N et al (2022) Cell-Free DNA promotes inflammation in patients with oral lichen planus via the STING Pathway